PeptideDB

Soyasaponin Ac

CAS No.: 133882-74-3

Soyasaponin Ac can decrease the drug resistance via EMT pathway and weaken the migration ability of ovarian cancer cells
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Soyasaponin Ac can decrease the drug resistance via EMT pathway and weaken the migration ability of ovarian cancer cells.
In vitro Cell viability assay was used to analyze the drug resistance of A2780/PTX cells treated with four different common soyasaponins respectively,in order to screen out the most effective soyasaponin. Then,the most effective soyasaponin was used to detect the expression of epithelial-mesenchymal transition (EMT)-related marker proteins, including N-cadherin and E-cadherin,with Western blot and confocal microscopy. Finally,transwell assay and wound healing assay were applied to observe effect of soyasaponin on regulating cancer cell migration. Compared with other soyasaponins,Soyasaponin Ac most effectively reversed the drug resistance of A2780/PTX cells. The expression of N-cadherin decreased while that of Ecadherin increased in A2780/PTX cells when treated with Soyasaponin Ac for 48 h. The results of transwell and wound healing assay suggested that Soyasaponin Ac also reduced the migration of A2780/PTX cells.
molecular weight 1421.52
Molecular formula C67H104O32
CAS 133882-74-3
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Effect of soyasaponin on drug resistance of ovarian cancer cells.Chinese Pharmacological Bulletin, 2018.